Skip to main content

News

You are here

UM Ventures News

UM Ventures News
Partner News

Hoth Therapeutics to Further its Research of VNLG-152 and Plans Exercise of its Option Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.

Wednesday, January 29, 2020

New Nanoparticle Therapy Appears More Effective Than Standard Therapy at Treating Aggressive Breast Cancer

Thursday, January 16, 2020

UMB Begins Phase 3 of Novavax COVID-19 Vaccine Trial

Monday, January 6, 2020

Technical.ly Baltimore: UMB licenses technology to Y Combinator-backed biotech startup

Wednesday, December 4, 2019

GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound

Tuesday, December 3, 2019

BioBuzz: Success Breeds Success: How A $250M Acquisition Catalyzed Baltimore’s MedTech Ecosystem

Thursday, November 14, 2019

Continued Expansion of gel-e's Consumer Products Label

Thursday, October 31, 2019

Technical.ly Baltimore: CoapTech wins $1.2M grant for Baltimore clinical trial

Thursday, October 24, 2019

CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

Monday, October 21, 2019

Technical.ly Baltimore: NeoProgen, led by former Harpoon Medical CEO, raises $1.5M from Maryland investors

Thursday, October 17, 2019

Pages